Lisdexamfetamine Dimesylate 42291-0039
Generic: Lisdexamfetamine
Product NDC
42291-0039- Manufacturer
- Avkare
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- June 4, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA202830
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 50 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
90 CAPSULE in 1 BOTTLE (42291-039-90)